论文信息 - Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition - 字舞流文

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

N. Reinmuth | C. Belka | Minglun Li | J. Ricke | M. Unterrainer | W. Kunz | C. Eze | F. Manapov | A. Tufman | J. Taugner | L. Käsmann | L. Mittlmeier | P. Bartenstein